198 related articles for article (PubMed ID: 33673084)
21. Hybrid silica-coated Gd-Zn-Cu-In-S/ZnS bimodal quantum dots as an epithelial cell adhesion molecule targeted drug delivery and imaging system.
Akbarzadeh M; Babaei M; Abnous K; Taghdisi SM; Peivandi MT; Ramezani M; Alibolandi M
Int J Pharm; 2019 Oct; 570():118645. PubMed ID: 31465835
[TBL] [Abstract][Full Text] [Related]
22. Polymer-Grafted Mesoporous Silica Nanoparticles as Ultrasound-Responsive Drug Carriers.
Paris JL; Cabañas MV; Manzano M; Vallet-Regí M
ACS Nano; 2015 Nov; 9(11):11023-33. PubMed ID: 26456489
[TBL] [Abstract][Full Text] [Related]
23. High-throughput preparation of hexagonally ordered mesoporous silica and gadolinosilicate nanoparticles for use as MRI contrast agents.
Tse NM; Kennedy DF; Moffat BA; Kirby N; Caruso RA; Drummond CJ
ACS Comb Sci; 2012 Aug; 14(8):443-50. PubMed ID: 22676496
[TBL] [Abstract][Full Text] [Related]
24. Fabrication of uniform magnetic nanocomposite spheres with a magnetic core/mesoporous silica shell structure.
Zhao W; Gu J; Zhang L; Chen H; Shi J
J Am Chem Soc; 2005 Jun; 127(25):8916-7. PubMed ID: 15969545
[TBL] [Abstract][Full Text] [Related]
25. Synthesis of double mesoporous core-shell silica spheres with tunable core porosity and their drug release and cancer cell apoptosis properties.
El-Toni AM; Khan A; Ibrahim MA; Labis JP; badr G; Al-Hoshan M; Yin S; Sato T
J Colloid Interface Sci; 2012 Jul; 378(1):83-92. PubMed ID: 22551476
[TBL] [Abstract][Full Text] [Related]
26. Novel scheme for rapid synthesis of hollow mesoporous silica nanoparticles (HMSNs) and their application as an efficient delivery carrier for oral bioavailability improvement of poorly water-soluble BCS type II drugs.
Li T; Geng T; Md A; Banerjee P; Wang B
Colloids Surf B Biointerfaces; 2019 Apr; 176():185-193. PubMed ID: 30616109
[TBL] [Abstract][Full Text] [Related]
27. Facile synthesis of yolk-shell magnetic mesoporous carbon microspheres for efficient enrichment of low abundance peptides.
Wan H; Qin H; Xiong Z; Zhang W; Zou H
Nanoscale; 2013 Nov; 5(22):10936-44. PubMed ID: 24061763
[TBL] [Abstract][Full Text] [Related]
28. Study of UV-shielding properties of novel porous hollow silica nanoparticle carriers for avermectin.
Li ZZ; Chen JF; Liu F; Liu AQ; Wang Q; Sun HY; Wen LX
Pest Manag Sci; 2007 Mar; 63(3):241-6. PubMed ID: 17177171
[TBL] [Abstract][Full Text] [Related]
29. Synthesis of Podlike Magnetic Mesoporous Silica Nanochains for Use as Enzyme Support and Nanostirrer in Biocatalysis.
Zhang T; Huang B; Elzatahry AA; Alghamdi A; Yue Q; Deng Y
ACS Appl Mater Interfaces; 2020 Apr; 12(15):17901-17908. PubMed ID: 32207600
[TBL] [Abstract][Full Text] [Related]
30. Facile synthesis of mesoporous silica nanoparticles using modified sol-gel method: Optimization and in vitro cytotoxicity studies.
Mehmood Y; Khan IU; Shahzad Y; Khalid SH; Asghar S; Irfan M; Asif M; Khalid I; Yousaf AM; Hussain T
Pak J Pharm Sci; 2019 Jul; 32(4(Supplementary)):1805-1812. PubMed ID: 31680076
[TBL] [Abstract][Full Text] [Related]
31. Hierarchically mesoporous silica nanoparticles: extraction, amino-functionalization, and their multipurpose potentials.
Du X; He J
Langmuir; 2011 Mar; 27(6):2972-9. PubMed ID: 21332153
[TBL] [Abstract][Full Text] [Related]
32. Hierarchical Mesoporous Organosilica-Silica Core-Shell Nanoparticles Capable of Controlled Fungicide Release.
Luo L; Liang Y; Erichsen ES; Anwander R
Chemistry; 2018 May; 24(28):7200-7209. PubMed ID: 29572993
[TBL] [Abstract][Full Text] [Related]
33. Biocompatible superparamagnetic core-shell nanoparticles for potential use in hyperthermia-enabled drug release and as an enhanced contrast agent.
Patil-Sen Y; Torino E; De Sarno F; Ponsiglione AM; Chhabria V; Ahmed W; Mercer T
Nanotechnology; 2020 Sep; 31(37):375102. PubMed ID: 32392545
[TBL] [Abstract][Full Text] [Related]
34. Mesoporous Silica Platforms with Potential Applications in Release and Adsorption of Active Agents.
Chircov C; Spoială A; Păun C; Crăciun L; Ficai D; Ficai A; Andronescu E; Turculeƫ ȘC
Molecules; 2020 Aug; 25(17):. PubMed ID: 32825791
[TBL] [Abstract][Full Text] [Related]
35. Impacts of mesoporous silica nanoparticle size, pore ordering, and pore integrity on hemolytic activity.
Lin YS; Haynes CL
J Am Chem Soc; 2010 Apr; 132(13):4834-42. PubMed ID: 20230032
[TBL] [Abstract][Full Text] [Related]
36. Simple way to obtain pH-sensitive drug release from functional mesoporous silica materials.
Xiang D; Lin H; Guo W; Ma J; Cui L; Jiang J; Qu F
IET Nanobiotechnol; 2014 Dec; 8(4):179-83. PubMed ID: 25429494
[TBL] [Abstract][Full Text] [Related]
37. Fe
García L; Garaio E; López-Ortega A; Galarreta-Rodriguez I; Cervera-Gabalda L; Cruz-Quesada G; Cornejo A; Garrido JJ; Gómez-Polo C; Pérez-Landazábal JI
Langmuir; 2023 Jan; 39(1):211-219. PubMed ID: 36562662
[TBL] [Abstract][Full Text] [Related]
38. 1.9 μm superficially porous packing material with radially oriented pores and tailored pore size for ultra-fast separation of small molecules and biomolecules.
Min Y; Jiang B; Wu C; Xia S; Zhang X; Liang Z; Zhang L; Zhang Y
J Chromatogr A; 2014 Aug; 1356():148-56. PubMed ID: 24999068
[TBL] [Abstract][Full Text] [Related]
39. Membrane interactions of mesoporous silica nanoparticles as carriers of antimicrobial peptides.
Braun K; Pochert A; Lindén M; Davoudi M; Schmidtchen A; Nordström R; Malmsten M
J Colloid Interface Sci; 2016 Aug; 475():161-170. PubMed ID: 27174622
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
